Ixazomib
Back to searchMolecule Structure
Scientific Name
Ixazomib
Description of the Drug
Ixazomib is a monoclonal antibody used with other medications to treat multiple myeloma in patients who have received one other therapy already.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB09570
http://www.drugbank.ca/drugs/DB09570
Brand Name(s)
Ninlaro
Company Owner(s)
Not Available
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| 26S proteasome | PROTEIN COMPLEX | INHIBITOR | CHEMBL2364701 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL3742758 |
| DrugBank | DB09570 |
| PubChem: Thomson Pharma | 57291607 |
| PubChem | 25183872 |
| LINCS | LSM-4944 |
| Nikkaji | J3.602.191H |
| PDBe | 6V8 |
| BindingDB | 50398609 |
| DrugCentral | 5067 |
| Metabolights | MTBLC90942 |
| Brenda | 235313 |
| ChemicalBook | CB62521080 |
| Guide to Pharmacology | 8450 |
| rxnorm | IXAZOMIB |
| ChEBI | 90942 |
| ZINC | ZINC000169946773 |
